Justification for other than full and open competition - Indianapolis, IN
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- 1IN2138
- Agency
-
Region 5
Public Buildings Service, General Services Administration
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- GS-05P-LIN18295
- NAICS code
- Not on record
- PSC
- X1AA Lease/Rental Of Office Buildings
- Place of performance
- Indianapolis, Indiana 46204, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Limited / Sole Source Justification Notice is for a 3-year lease extension for the Food and Drug Administration (FDA) office located in Indianapolis, Indiana. The General Services Administration (GSA) has determined that the extension is necessary due to unexpected delays in the FDA's relocation to other federally controlled space. The current lease under contract number LIN18295 is set to expire on May 5, 2024. The justification cites cost and mission-based rationales, noting that the extension avoids the costs of a holdover tenancy and that the FDA's unique location requirements cannot be satisfied elsewhere. The contract will be awarded to an unknown vendor for an unknown amount on May 9, 2024.
Notice text
Awarded contract GS-05P-LIN18295 to unknown vendor for unknown amount on 2024-05-09.
Files
| File | Type | Posted |
|---|---|---|
| FDA Indianapolis Justification Memo REDACTED_Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Limited / Sole Source Justification | |
| Intent to Renew Lease in Indianapolis, IN | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity